Study on detection of aberrant promoter hypermethylation of p16 and DAP kinase in serum DNA from patients with non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 5, Issue 3, 2002, Pages 188-190

  Wu, Jun ^a   Liang, Biao ^a   He, Jianyou ^a   Zhang, HaiTao ^a   Wang, Zhigang ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

DAP; Methylation; Non small lung cancer; p16; Serum

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; PROTEIN KINASE; PROTEIN P16; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EARLY DIAGNOSIS; FEASIBILITY STUDY; FEMALE; GENETIC ANALYSIS; HUMAN; LUNG NON SMALL CELL CANCER; MALE; METHYLATION; POLYMERASE CHAIN REACTION;

EID: 0036081644     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. DAP kinase links the control of apoptosis to metastasis
2. Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer
3. DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: Possible implications for role as tumor suppressor gene
4. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients
5. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients
6. Hypermethylation of the DAP-Kinase CpG island is a common alteration in B-cell malignancis
7. DNA methylation: Past, present and future directions
8. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage
9. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients